Replies to post #8430 on BioCorRx Inc. (BICX)

[BearsNBulls]

$3 a share, I'd be ecstatic with $2 a share. Vivatrol which is produced by Alkermes (ALKS) generates 30% of the total revenue for Alkermes. Imagine when BICX101 the injectable is approved. It will force Alkermes into action to buy-out, or another company to do so.

BioCorRx is definitely a long play. I'd estimate 1-2 years from now at most.